SFA
ONC

Sequoia Financial Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Sequoia Financial Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Sell
1,441
-187
-11% -$55.1K ﹤0.01% 1465
2026
Q1 		$483K Buy
1,628
+65
+4% +$21K ﹤0.01% 1300
2025
Q4 		$475K Buy
1,563
+282
+22% +$92.3K ﹤0.01% 1308
2025
Q3 		$436K Buy
1,281
+50
+4% +$15.2K ﹤0.01% 1198
2025
Q2 		$298K Buy
1,231
+97
+9% +$23.8K ﹤0.01% 1266
2025
Q1 		$309K Buy
+1,134
New +$265K ﹤0.01% 1052

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sequoia Financial Advisors's ONC Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its BeOne Medicines Ltd (ONC) stake by 11% in Q2 2026, selling an estimated $55.1K and leaving 1,441 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Sequoia Financial Advisors first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. The position peaked at $483K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Sequoia Financial Advisors held 1,441 shares of BeOne Medicines Ltd worth $411K as of Q2 2026.
  • Sequoia Financial Advisors sold 187 BeOne Medicines Ltd shares in Q2 2026, an estimated $55.1K.
  • BeOne Medicines Ltd made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1465 holding.
  • Sequoia Financial Advisors first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • Sequoia Financial Advisors's BeOne Medicines Ltd position peaked at $483K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.